114 related articles for article (PubMed ID: 30828645)
21. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
[TBL] [Abstract][Full Text] [Related]
22. Imaging mosquito transmission of Plasmodium sporozoites into the mammalian host: immunological implications.
Vanderberg JP
Parasitol Int; 2014 Feb; 63(1):150-64. PubMed ID: 24060541
[TBL] [Abstract][Full Text] [Related]
23. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
[TBL] [Abstract][Full Text] [Related]
24. Acute malaria prolongs susceptibility of mice to Plasmodium berghei sporozoite infection.
Orjih AU
Clin Exp Immunol; 1985 Jul; 61(1):67-71. PubMed ID: 3899429
[TBL] [Abstract][Full Text] [Related]
25. Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso.
Migot F; Ouedraogo JB; Diallo J; Zampan H; Dubois B; Scott-Finnigan T; Sanou PT; Deloron P
Parasite Immunol; 1996 Jul; 18(7):333-9. PubMed ID: 9229386
[TBL] [Abstract][Full Text] [Related]
26. Use of non-human primate hepatocytes for in vitro study of the pre-erythrocytic stages of malaria parasites.
Millet P; Collins WE; Aikawa M; Cochrane AH; Nguyen-Dinh P
Bull World Health Organ; 1990; 68 Suppl(Suppl):60-5. PubMed ID: 2094593
[TBL] [Abstract][Full Text] [Related]
27. Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malaria.
Addai-Mensah O; Seidel M; Amidu N; Maskus DJ; Kapelski S; Breuer G; Franken C; Owusu-Dabo E; Frempong M; Rakotozandrindrainy R; Schinkel H; Reimann A; Klockenbring T; Barth S; Fischer R; Fendel R
Malar J; 2016 Feb; 15():65. PubMed ID: 26850066
[TBL] [Abstract][Full Text] [Related]
28. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
Dutta S; Tewari A; Balaji C; Verma R; Moitra A; Yadav M; Agrawal P; Sahal D; Jarori GK
Malar J; 2018 Aug; 17(1):304. PubMed ID: 30126436
[TBL] [Abstract][Full Text] [Related]
29. The march toward malaria vaccines.
Hoffman SL; Vekemans J; Richie TL; Duffy PE
Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
[TBL] [Abstract][Full Text] [Related]
30. High Sporozoite Antibody Titers in Conjunction with Microscopically Detectable Blood Infection Display Signatures of Protection from Clinical Malaria.
Offeddu V; Olotu A; Osier F; Marsh K; Matuschewski K; Thathy V
Front Immunol; 2017; 8():488. PubMed ID: 28533773
[TBL] [Abstract][Full Text] [Related]
31. Blood Stage Malaria Disrupts Humoral Immunity to the Pre-erythrocytic Stage Circumsporozoite Protein.
Keitany GJ; Kim KS; Krishnamurty AT; Hondowicz BD; Hahn WO; Dambrauskas N; Sather DN; Vaughan AM; Kappe SHI; Pepper M
Cell Rep; 2016 Dec; 17(12):3193-3205. PubMed ID: 28009289
[TBL] [Abstract][Full Text] [Related]
32. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
[TBL] [Abstract][Full Text] [Related]
33. Immune response to pre-erythrocytic stages of malaria parasites.
Doolan DL; Martinez-Alier N
Curr Mol Med; 2006 Mar; 6(2):169-85. PubMed ID: 16515509
[TBL] [Abstract][Full Text] [Related]
34. Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen.
Fidock DA; Pasquetto V; Gras H; Badell E; Eling W; Ballou WR; Belghiti J; Tartar A; Druilhe P
Eur J Immunol; 1997 Oct; 27(10):2502-13. PubMed ID: 9368603
[TBL] [Abstract][Full Text] [Related]
35. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
[TBL] [Abstract][Full Text] [Related]
36. Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso.
Cherif MK; Ouédraogo O; Sanou GS; Diarra A; Ouédraogo A; Tiono A; Cavanagh DR; Michael T; Konaté AT; Watson NL; Sanza M; Dube TJT; Sirima SB; Nebié I
BMC Res Notes; 2017 Sep; 10(1):472. PubMed ID: 28886727
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity in the acquisition of naturally acquired antibodies to cell-traversal protein for ookinetes and sporozoites (CelTOS) and thrombospondin-related adhesion protein (TRAP) of Plasmodium falciparum in naturally infected patients from unstable malaria areas in Iran.
Pirahmadi S; Zakeri S; Mehrizi AA; Karimi L; Djadid ND
Acta Trop; 2019 Feb; 190():365-374. PubMed ID: 30543766
[TBL] [Abstract][Full Text] [Related]
38. An epidemiological study to assess Plasmodium falciparum parasite prevalence and malaria control measures in Burkina Faso and Senegal.
Diallo A; Sié A; Sirima S; Sylla K; Ndiaye M; Bountogo M; Ouedraogo E; Tine R; Ndiaye A; Coulibaly B; Ouedraogo A; Faye B; Ba EH; Compaore G; Tiono A; Sokhna C; Yé M; Diarra A; Bahmanyar ER; De Boer M; Pirçon JY; Usuf EA
Malar J; 2017 Feb; 16(1):63. PubMed ID: 28166794
[TBL] [Abstract][Full Text] [Related]
39. Immunity to Plasmodium sporozoites: recent advances and applications to field research.
Esposito F; Lombardi S; Modiano D; Zavala F; Reeme J; Lamizana L; Coluzzi M; Nussenzweig RS
Parassitologia; 1986; 28(2-3):101-5. PubMed ID: 2459653
[TBL] [Abstract][Full Text] [Related]
40. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C
J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
